Achieving reimbursement today demands a crystal-clear strategy and communication: evidence that meets payer requirements, narratives that demonstrate real-world value and tailored insight into country-specific decision making.
Valid Insight is a dedicated market-access consultancy within the Bioscript Group, guiding products from first-in-human studies through loss of exclusivity.
How we support the full lifecycle
Typical Outputs
-
Evidence reviews and gaps analysis
-
Early value assessment
-
Evidence synthesis
-
Launch and sequencing strategies
-
Payer, clinician and key opinion leader primary research
-
Development of 3M objection handlers (Medical, Marketing and Market Access)
-
Pricing strategy and access roadmaps
-
Stakeholder validated payer value communication material
-
Negotiation pathway guides
-
Negotiation excellence training and mock negotiations
-
Tender risk assessments, strategy design and implementation training
-
Beyond price differentiation strategies (service models, ESG credentials, real-world data packages, etc.)
WHY CLIENTS LOVE TO WORK WITH VALID INSIGHT
AN OVERVIEW OF VALID INSIGHT
Ready to map a clear route to optimal access?
Alternatively, you can email us at discover@bioscriptgroup.com or call +44 (0)333 222 4269
